COVID-19 Pneumonia — Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells
Citation(s)
Double Blind, Placebo-controlled, Phase I/II Clinical Trial to Evaluate Safety and Efficacy of Allogeneic Mesenchymal Stem/Stromal Cells MSV-allo for Treatment of Acute Respiratory Failure in Patients With COVID-19 Pneumonia (MSV-COVID)